Trusted by:
Israeli biologists have demonstrated that a specific protein induces breast cancer cells to invade other tissues and acquire properties that are characteristic of metastatic tumor cells.
A novel FDA-approved device easily and reliably identifies the onset and duration of REM sleep by tracking changes in the blood flow through the finger. This could have strong implications for prevention of heart attacks and other cardiac events by identifying physiological changes unique to this stage of sleep that may signal cardiac stress.
Shoppers confronted with the "paper or plastic" question in the supermarket checkout may soon also need to decide whether they want their perishables in plain or basil wrapping.
Computing may be getting a lot more personal. Researchers have developed software that is able to identify computer users by their individual, distinct typing styles. This "behaviometric" technology may one day be part of security systems to prevent unauthorized users from gaining access to computers and sensitive data.
Can agriculture actually benefit the environment? It can, according to the suprising findings of a recent study, which show that in certain cases agriculture can solve ecological problems.
Researchers at the Technion-Israel Institute of Technology have discovered that the body possesses a second set of beneficial antibodies that suppress the activity of the self destructive immunity. They were also able to boost the restraining activity of the beneficial antibodies.
Researchers have succeeded in inducing embryonic stem cells to differentiate into the cells that make up blood vessels - and to actually form the vessels themselves.
A simple blood test could determine whether older women with diabetes would benefit from--or be harmed by--vitamin doses designed to protect their ailing hearts, according to researchers.
Researchers have uncovered significant clues for treating acquired renal failure by deciphering the genetic cause of a rare and inherited childhood skin disease.
A new cancer treatment developed by Israeli scientists has been shown to eliminate or shrink tumors in laboratory mice. The treatment causes anti-viral T cells (white blood cells that play a large role in the body's primary immune response) to recognize tumors as virus-infected cells, and thus attack them.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right